Abstract:
:Glioblastoma multiforme (GBM) represents one of the most frequent malignant brain tumors. Current therapies do not provide real solutions to this pathology. Their failure can be ascribed to a cell subpopulation with stem-like properties called glioma stem cells (GSCs). Therefore, new therapeutic strategies GSC-targeted are needed. PPARγ, a nuclear receptor involved in lipid metabolism, has already been indicated as a promising target for antineoplastic therapies. Recent studies have reported that synthetic PPARγ agonists, already in clinical use for the treatment of type II diabetes, exhibit antineoplastic effects in a wide range of malignant tumor cells, including glioma cells. We investigated the effect of the synthetic PPARγ agonist Pioglitazone on viability, proliferation, morphology, and differentiation in six GSC lines isolated from GBM patients. We also analyzed Pioglitazone-induced changes in transcriptional levels of Wnt/β catenin related genes. Results showed that response to Pioglitazone was heterogeneous inducing an evident decrease of cell viability and proliferation only in a subset of GSC lines. We did not find any sign of cell differentiation neither observing cell morphology nor analyzing the expression of stemness and differentiation markers. Moreover, Wnt/β signaling pathway was only mildly affected from a transcriptional point of view after Pioglitazone exposure.
journal_name
PPAR Resjournal_title
PPAR researchauthors
Cilibrasi C,Butta V,Riva G,Bentivegna Adoi
10.1155/2016/7175067subject
Has Abstractpub_date
2016-01-01 00:00:00pages
7175067eissn
1687-4757issn
1687-4765journal_volume
2016pub_type
杂志文章相关文献
PPAR Research文献大全abstract::The cyclopentenone prostaglandin 15-deoxy-Δ(12,14)-prostaglandin J2 (15d-PGJ2) is a natural ligand of peroxisome proliferator-activated receptor gamma (PPAR-γ) and a potential mediator of apoptosis in cancer cells. In the present study, we evaluated the effect of 15d-PGJ2 in human thyroid papillary carcinoma cells (TP...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2016/4106297
更新日期:2016-01-01 00:00:00
abstract::Pancreatic cancer is a devastating disease in which current therapies are inadequate. Separate lines of research have identified the 5-lipoxygenase/leukotriene B(4) receptor pathway and the PPARgamma pathway as potential targets for prevention or treatment of this disease. LY293111 was originally designed as a potent ...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/827096
更新日期:2008-01-01 00:00:00
abstract::Hyperhomocysteinemia, a risk factor for vascular disease, is associated with metabolic syndrome. Our study was aimed at exploring the effect of long-term hyperhomocysteinemia with metabolic disturbances on vascular remodeling. We also studied oxidative stress and expression of PPARγ in the coronary arteriole as a poss...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2018/6738703
更新日期:2018-01-15 00:00:00
abstract::Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor (NR) superfamily of ligand-activated transcriptional factors. Among other functions, PPAR-gamma acts as a key regulator of the adipogenesis. Since several cytokines (IL-1, TNF-alpha, TGF-beta) had been known to inhibit ad...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2010/341671
更新日期:2010-01-01 00:00:00
abstract::Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) is a ligand-activated transcription factor with essential functions in the regulation of lipid catabolism, glucose homeostasis, and inflammation, which makes it a potentially relevant drug target for the treatment of major human diseases. In additi...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/614852
更新日期:2008-01-01 00:00:00
abstract::Peroxisome proliferator-activated receptor-gamma (PPARgamma), one of three ligand-activated transcription factors named PPAR, has been identified as a molecular target for cancer chemopreventive agents. PPARgamma was initially understood as a regulator of adipocyte differentiation and glucose homeostasis while later o...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/436489
更新日期:2008-01-01 00:00:00
abstract::The peroxisome proliferator-activated receptors (PPARs), which are ligand-inducible transcription factors expressed in a variety of tissues, have been shown to perform key roles in lipid homeostasis. In physiological situations such as fasting and physical exercise, one PPAR subtype, PPARdelta, triggers a transcriptio...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/172676
更新日期:2008-01-01 00:00:00
abstract::Pioglitazone (Pio) is a thiazolidinedione (TZD) insulin-sensitizing drug whose effects result predominantly from its modulation of the transcriptional activity of peroxisome proliferator-activated-receptor-gamma (PPARγ). Pio is used to treat human insulin-resistant diabetes and also frequently considered for treatment...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2020/3817573
更新日期:2020-09-10 00:00:00
abstract:BACKGROUND:Both peroxisome activator proteins (PPARs) and fetuin-A play a role in lipid and glucose metabolism. AIMS:We investigated whether PPARα intron 7 G2468/C and PPARγ2 Pro12Ala and PPARγ exon 6 C161T polymorphisms are associated with serum fetuin-A concentrations. PATIENTS AND METHODS:The PPARα intron 7 G/C po...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2017/7636019
更新日期:2017-01-01 00:00:00
abstract::The past decade of PPARγ research has dramatically improved our understanding of the structural and mechanistic bases for the diverging physiological effects of different classes of PPARγ ligands. The discoveries that lie at the heart of these developments have enabled the design of a new class of PPARγ ligands, capab...
journal_title:PPAR research
pub_type: 杂志文章,评审
doi:10.1155/2020/9657380
更新日期:2020-07-01 00:00:00
abstract::The upregulation of peroxisome proliferator-activated receptor gamma (PPARG) has been shown to increase the chemosensitivity of several human cancers. This study is aimed at studying if PPARG sensitizes hypopharyngeal squamous cell carcinoma (HSCC) in chemotherapeutic treatments and at dissecting possible mechanisms o...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2020/6452182
更新日期:2020-04-22 00:00:00
abstract::High mobility group box 1 (HMGB1) is a ubiquitous nuclear DNA-binding protein whose function is dependent on its cellular location. Extracellular HMGB1 is regarded as a delayed mediator of proinflammatory cytokines for initiating and amplifying inflammatory responses, whereas nuclear HMGB1 has been found to prevent ca...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2014/541394
更新日期:2014-01-01 00:00:00
abstract::While TOFA (acetyl CoA carboxylase inhibitor) and C75 (fatty acid synthase inhibitor) prevent lipid accumulation by inhibiting fatty acid synthesis, the mechanism of action is not simply accounted for by inhibition of the enzymes alone. Liver fatty acid binding protein (L-FABP), a mediator of long chain fatty acid sig...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2013/865604
更新日期:2013-01-01 00:00:00
abstract::INT131 (formerly T0903131, T131, AMG131) is a potent non-thiazolidinedione (TZD) selective peroxisome proliferator-activated receptor gamma modulator (SPPARM) currently in Phase 2 clinical trials for treatment of type-2 diabetes mellitus (T2DM). This new chemical entity represents a second generation SPPARM approach d...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/936906
更新日期:2008-01-01 00:00:00
abstract::Peroxisome proliferator-activated receptor gamma (PPARγ) activation decreased serum testosterone (T) in women with hyperthecosis and/or polycystic ovary syndrome and reduced the conversion of androgens to estradiol (E2) in female rats. This implies modulation of female sex steroid hormones by PPARγ. It is not clear if...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2009/101857
更新日期:2009-01-01 00:00:00
abstract::To investigate the effects of fimasartan on nonalcoholic fatty liver disease in hyperlipidemic and hypertensive conditions, the levels of biomarkers related to fatty acid metabolism were determined in HepG2 and differentiated 3T3-L1 cells treated by high fatty acid and liver and visceral fat tissue samples of spontane...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2017/8048720
更新日期:2017-01-01 00:00:00
abstract::PPAR isotypes are involved in the regulation of cell proliferation, death, and differentiation, with different roles and mechanisms depending on the specific isotype and ligand and on the differentiated, undifferentiated, or transformed status of the cell. Differentiation stimuli are integrated by key transcription fa...
journal_title:PPAR research
pub_type: 杂志文章,收录出版
doi:10.1155/2007/48242
更新日期:2007-01-01 00:00:00
abstract::Cells can shift their metabolism between glycolysis and oxidative phosphorylation to enact their cell fate program in response to external signals. Widely distributed α1-adrenergic receptors (ARs) are physiologically stimulated during exercise, were reported to associate with the activating energetic AMPK pathway, and...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2020/3785137
更新日期:2020-02-01 00:00:00
abstract::Nitrooleic acid (OA-NO2) is endogenous ligands for peroxisome proliferator-activated receptors. The present study was aimed at investigating the beneficial effects of OA-NO2 on the lipid metabolism and liver steatosis in deoxycorticosterone acetate- (DOCA-) salt induced hypertensive mice model. Male C57BL/6 mice were ...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2015/480348
更新日期:2015-01-01 00:00:00
abstract::Infection with Mycobacterium tuberculosis (TB) induces pulmonary immunopathology mediated by classical Th1 type of acquired immunity with hepatic involvement in up to 80% of disseminated cases. Since PPAR agonists cause immune responses characterized by a decrease in the secretion of Th1 cytokines, we investigated the...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2007/49671
更新日期:2007-01-01 00:00:00
abstract::The peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist rosiglitazone inhibits NF-κB expression and endogenous neural stem cell differentiation into neurons and reduces the inflammatory cascade after spinal cord injury (SCI). The aim of this study was to explore the mechanisms underlying rosiglitazone-me...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2018/3897478
更新日期:2018-06-21 00:00:00
abstract::Dysfunction of macro- and microvessels is a major cause of morbidity and mortality in patients with cardio-renovascular diseases such as atherosclerosis, hypertension, and diabetes. Renal failure and impairment of renal function due to vasoconstriction of the glomerular arteriole in diabetic nephropathy leads to renal...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2010/806538
更新日期:2010-01-01 00:00:00
abstract::Protein farnesylation is required for the activation of multiple proteins involved in cell differentiation and function. In white adipose tissue protein, farnesylation has shown to be essential for the successful differentiation of preadipocytes into adipocytes. We hypothesize that protein farnesylation is required fo...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2007/81654
更新日期:2007-01-01 00:00:00
abstract::Foxp3(+) regulatory T cells (Tregs) play a critical role in maintaining immune self-tolerance. Reduced number and activity of Tregs are usually found in autoimmune and inflammatory diseases, and enhancing the differentiation of Tregs may be a promising therapeutic strategy. Some reports suggested an anti-inflammatory ...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2012/529035
更新日期:2012-01-01 00:00:00
abstract::It has been proposed that PPAR-dependent, accelerated catabolism of proinflammatory mediators may contribute to the fast resolution of inflammation. Because retinoid X receptors are obligate heterodimer partners of PPARs, we investigated the impact of deleting hepatocyte-specific RXRalpha on the antiedema effect of PP...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/PPAR/2006/96341
更新日期:2006-01-01 00:00:00
abstract::PPARγ agonists can either enhance or inhibit eosinophil migration, which is a sum of directional migration (chemotaxis) and random cell movement (chemokinesis). To date, the effects of PPAR agonists on chemokinesis have not been examined. This study investigates the effects of PPARα, δ, and γ agonists on eosinophil mi...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2012/235231
更新日期:2012-01-01 00:00:00
abstract::During pregnancy crucial anatomic, physiologic, and metabolic changes challenge the mother and the fetus. The placenta is a remarkable organ that allows the mother and the fetus to adapt to the new metabolic, immunologic, and angiogenic environment imposed by gestation. One of the physiologic systems that appears to h...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/527048
更新日期:2008-01-01 00:00:00
abstract::Stroke (focal cerebral ischemia) is a leading cause of death and disability among adult population. Many pathological events including inflammation and oxidative stress during the acute period contributes to the secondary neuronal death leading the neurological dysfunction after stroke. Transcriptional regulation of g...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2008/461981
更新日期:2008-01-01 00:00:00
abstract::Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of the women of reproductive age. Familial clustering of PCOS has been consistently reported suggesting that genetic factors play a role in the development of the syndrome although PCOS cases do not exhibit a clear pattern of Mendelian inheritance....
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2007/49109
更新日期:2007-01-01 00:00:00
abstract::Peroxisome proliferator-activated receptors (PPAR alpha, beta/delta and gamma) play a key role in metabolic regulatory processes and gene regulation of cellular metabolism, particularly in the cardiovascular system. Moreover, PPARs have various extra metabolic roles, in circadian rhythms, inflammation and oxidative st...
journal_title:PPAR research
pub_type: 杂志文章
doi:10.1155/2010/783273
更新日期:2010-01-01 00:00:00